Table 2

Monte Carlo performance of the HF estimator for estimating Cox model parameter in standard trial, based on 1,000 simulations. Each setting has an average of 1778 (94) placebo(vaccine) cases. Immune responses are measured at day 0, month 6, and year 1 post-peak time point. For model with x(t) only, β0=.5,β1=1; for model with x(t),x(0),β0=0.1,β1=.5,β2=.5; for model with x(t),t,β0=1.3,β1=1,β3=.5.

TrueWorking Model Vaccine
All
β1β2β3β0β1β2β3
bias×100
x(t)x(t)–1.490.52–0.39
x(t),x(0)0.64–1.723.14–1.03–0.24
x(t),t–1.680.514.54–1.53–2.83
x(t),x(0)x(t),x(0)–0.6–0.010.860.05–0.55
x(t)–20.39–149.88–9.76
x(0)–57.4565.6–56.27
x(t),x(0),t–1.140.45–1.471.15–1.060.48–2.75
x(t),tx(t),t–1.92–1.625.66–1.74–3.79
x(t)–4.6168.32–14.72
t–154.6168.32–164.72
x(t),x(0),t–2.681.56–3.63.59–2.351.17–5.51
Variance
x(t)x(t)0.0480.1270.022
x(t),x(0)0.240.081.7920.1760.027
x(t),t0.0531.3730.7190.0520.288
x(t),x(0)x(t),x(0)0.0860.2351.6440.030.169
x(t)0.0470.1490.022
x(0)0.1321.5180.126
x(t),x(0),t0.1060.2681.5411.6290.1050.2610.395
x(t),tx(t),t0.0461.3270.6440.0460.266
x(t)0.0420.110.02
t0.0420.110.02
x(t),x(0),t0.0830.2491.5041.6950.0820.2440.398
TrueWorking Model Vaccine
All
β1β2β3β0β1β2β3
bias×100
x(t)x(t)–1.490.52–0.39
x(t),x(0)0.64–1.723.14–1.03–0.24
x(t),t–1.680.514.54–1.53–2.83
x(t),x(0)x(t),x(0)–0.6–0.010.860.05–0.55
x(t)–20.39–149.88–9.76
x(0)–57.4565.6–56.27
x(t),x(0),t–1.140.45–1.471.15–1.060.48–2.75
x(t),tx(t),t–1.92–1.625.66–1.74–3.79
x(t)–4.6168.32–14.72
t–154.6168.32–164.72
x(t),x(0),t–2.681.56–3.63.59–2.351.17–5.51
Variance
x(t)x(t)0.0480.1270.022
x(t),x(0)0.240.081.7920.1760.027
x(t),t0.0531.3730.7190.0520.288
x(t),x(0)x(t),x(0)0.0860.2351.6440.030.169
x(t)0.0470.1490.022
x(0)0.1321.5180.126
x(t),x(0),t0.1060.2681.5411.6290.1050.2610.395
x(t),tx(t),t0.0461.3270.6440.0460.266
x(t)0.0420.110.02
t0.0420.110.02
x(t),x(0),t0.0830.2491.5041.6950.0820.2440.398
Table 2

Monte Carlo performance of the HF estimator for estimating Cox model parameter in standard trial, based on 1,000 simulations. Each setting has an average of 1778 (94) placebo(vaccine) cases. Immune responses are measured at day 0, month 6, and year 1 post-peak time point. For model with x(t) only, β0=.5,β1=1; for model with x(t),x(0),β0=0.1,β1=.5,β2=.5; for model with x(t),t,β0=1.3,β1=1,β3=.5.

TrueWorking Model Vaccine
All
β1β2β3β0β1β2β3
bias×100
x(t)x(t)–1.490.52–0.39
x(t),x(0)0.64–1.723.14–1.03–0.24
x(t),t–1.680.514.54–1.53–2.83
x(t),x(0)x(t),x(0)–0.6–0.010.860.05–0.55
x(t)–20.39–149.88–9.76
x(0)–57.4565.6–56.27
x(t),x(0),t–1.140.45–1.471.15–1.060.48–2.75
x(t),tx(t),t–1.92–1.625.66–1.74–3.79
x(t)–4.6168.32–14.72
t–154.6168.32–164.72
x(t),x(0),t–2.681.56–3.63.59–2.351.17–5.51
Variance
x(t)x(t)0.0480.1270.022
x(t),x(0)0.240.081.7920.1760.027
x(t),t0.0531.3730.7190.0520.288
x(t),x(0)x(t),x(0)0.0860.2351.6440.030.169
x(t)0.0470.1490.022
x(0)0.1321.5180.126
x(t),x(0),t0.1060.2681.5411.6290.1050.2610.395
x(t),tx(t),t0.0461.3270.6440.0460.266
x(t)0.0420.110.02
t0.0420.110.02
x(t),x(0),t0.0830.2491.5041.6950.0820.2440.398
TrueWorking Model Vaccine
All
β1β2β3β0β1β2β3
bias×100
x(t)x(t)–1.490.52–0.39
x(t),x(0)0.64–1.723.14–1.03–0.24
x(t),t–1.680.514.54–1.53–2.83
x(t),x(0)x(t),x(0)–0.6–0.010.860.05–0.55
x(t)–20.39–149.88–9.76
x(0)–57.4565.6–56.27
x(t),x(0),t–1.140.45–1.471.15–1.060.48–2.75
x(t),tx(t),t–1.92–1.625.66–1.74–3.79
x(t)–4.6168.32–14.72
t–154.6168.32–164.72
x(t),x(0),t–2.681.56–3.63.59–2.351.17–5.51
Variance
x(t)x(t)0.0480.1270.022
x(t),x(0)0.240.081.7920.1760.027
x(t),t0.0531.3730.7190.0520.288
x(t),x(0)x(t),x(0)0.0860.2351.6440.030.169
x(t)0.0470.1490.022
x(0)0.1321.5180.126
x(t),x(0),t0.1060.2681.5411.6290.1050.2610.395
x(t),tx(t),t0.0461.3270.6440.0460.266
x(t)0.0420.110.02
t0.0420.110.02
x(t),x(0),t0.0830.2491.5041.6950.0820.2440.398
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close